Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications | 9 | 2023 | 400 | 1.990 |
Why?
|
| Opioid-Related Disorders | 7 | 2022 | 400 | 1.850 |
Why?
|
| Maternal Death | 2 | 2023 | 7 | 1.680 |
Why?
|
| Buprenorphine | 6 | 2021 | 151 | 1.570 |
Why?
|
| Suicide | 2 | 2023 | 85 | 1.530 |
Why?
|
| Postpartum Period | 7 | 2022 | 109 | 1.250 |
Why?
|
| Substance-Related Disorders | 4 | 2023 | 609 | 1.100 |
Why?
|
| Pregnancy | 15 | 2023 | 2679 | 1.040 |
Why?
|
| Psychiatric Department, Hospital | 1 | 2025 | 4 | 0.940 |
Why?
|
| Narcotic Antagonists | 3 | 2021 | 139 | 0.860 |
Why?
|
| Inpatients | 1 | 2025 | 209 | 0.820 |
Why?
|
| Drug Overdose | 1 | 2023 | 165 | 0.710 |
Why?
|
| Psychotic Disorders | 1 | 2021 | 139 | 0.660 |
Why?
|
| Obstetrics | 1 | 2021 | 89 | 0.650 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2025 | 401 | 0.640 |
Why?
|
| Pregnant Women | 3 | 2022 | 70 | 0.600 |
Why?
|
| Mothers | 2 | 2020 | 268 | 0.590 |
Why?
|
| Suicidal Ideation | 2 | 2017 | 109 | 0.540 |
Why?
|
| Medication Adherence | 1 | 2018 | 133 | 0.540 |
Why?
|
| Self-Injurious Behavior | 1 | 2017 | 30 | 0.540 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2017 | 27 | 0.530 |
Why?
|
| Depression | 2 | 2020 | 604 | 0.500 |
Why?
|
| Female | 20 | 2025 | 28262 | 0.480 |
Why?
|
| Maternal Mortality | 2 | 2023 | 30 | 0.400 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 591 | 0.380 |
Why?
|
| Humans | 21 | 2025 | 52593 | 0.350 |
Why?
|
| Opiate Substitution Treatment | 3 | 2020 | 102 | 0.320 |
Why?
|
| Cause of Death | 2 | 2023 | 161 | 0.240 |
Why?
|
| Adult | 9 | 2025 | 14170 | 0.240 |
Why?
|
| Infant, Newborn | 4 | 2022 | 2891 | 0.220 |
Why?
|
| Comorbidity | 1 | 2025 | 631 | 0.200 |
Why?
|
| Substance Abuse Detection | 2 | 2020 | 89 | 0.200 |
Why?
|
| Advisory Committees | 1 | 2022 | 71 | 0.190 |
Why?
|
| Depression, Postpartum | 1 | 2022 | 46 | 0.190 |
Why?
|
| Anxiety | 2 | 2023 | 301 | 0.180 |
Why?
|
| Prevalence | 1 | 2025 | 1017 | 0.180 |
Why?
|
| Peripartum Period | 1 | 2021 | 15 | 0.180 |
Why?
|
| Magnetocardiography | 2 | 2019 | 38 | 0.180 |
Why?
|
| Brain | 2 | 2020 | 1325 | 0.180 |
Why?
|
| Methadone | 2 | 2019 | 183 | 0.170 |
Why?
|
| Psychometrics | 2 | 2023 | 230 | 0.170 |
Why?
|
| Hospitalization | 1 | 2025 | 749 | 0.160 |
Why?
|
| Urinalysis | 1 | 2019 | 33 | 0.160 |
Why?
|
| Fetal Heart | 1 | 2019 | 24 | 0.160 |
Why?
|
| Mental Health Services | 1 | 2022 | 212 | 0.150 |
Why?
|
| Pain | 1 | 2021 | 362 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 1 | 2018 | 86 | 0.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 197 | 0.150 |
Why?
|
| Fetal Monitoring | 1 | 2018 | 36 | 0.140 |
Why?
|
| Prospective Studies | 2 | 2021 | 2457 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 1217 | 0.140 |
Why?
|
| Magnetoencephalography | 1 | 2018 | 87 | 0.140 |
Why?
|
| Pregnancy Trimesters | 1 | 2017 | 13 | 0.140 |
Why?
|
| Georgia | 1 | 2017 | 42 | 0.140 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2018 | 168 | 0.140 |
Why?
|
| Fetus | 1 | 2018 | 195 | 0.130 |
Why?
|
| Young Adult | 4 | 2020 | 4337 | 0.130 |
Why?
|
| Pandemics | 1 | 2021 | 587 | 0.130 |
Why?
|
| Electroconvulsive Therapy | 1 | 2016 | 23 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 323 | 0.130 |
Why?
|
| Mood Disorders | 1 | 2016 | 59 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 148 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 883 | 0.120 |
Why?
|
| United States | 2 | 2023 | 5227 | 0.110 |
Why?
|
| Benzodiazepines | 3 | 2020 | 72 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2020 | 6671 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1686 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2291 | 0.090 |
Why?
|
| Middle Aged | 1 | 2025 | 13096 | 0.080 |
Why?
|
| Risk Factors | 1 | 2017 | 3952 | 0.070 |
Why?
|
| Heart Rate, Fetal | 2 | 2018 | 61 | 0.070 |
Why?
|
| Parturition | 1 | 2022 | 50 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 124 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 190 | 0.040 |
Why?
|
| Focus Groups | 1 | 2022 | 197 | 0.040 |
Why?
|
| Patient Dropouts | 1 | 2020 | 51 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2020 | 95 | 0.040 |
Why?
|
| Laboratories, Hospital | 1 | 2019 | 6 | 0.040 |
Why?
|
| Amphetamines | 1 | 2019 | 27 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2022 | 362 | 0.040 |
Why?
|
| Mental Health | 1 | 2022 | 240 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2020 | 110 | 0.040 |
Why?
|
| Fetal Movement | 1 | 2018 | 18 | 0.040 |
Why?
|
| Child Development | 1 | 2020 | 201 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2020 | 197 | 0.040 |
Why?
|
| Cocaine | 1 | 2019 | 177 | 0.040 |
Why?
|
| Mandatory Reporting | 1 | 2016 | 12 | 0.030 |
Why?
|
| Legislation, Drug | 1 | 2016 | 18 | 0.030 |
Why?
|
| Public Policy | 1 | 2016 | 38 | 0.030 |
Why?
|
| Obstetric Labor, Premature | 1 | 2016 | 35 | 0.030 |
Why?
|
| Heart Block | 1 | 2016 | 26 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 882 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 721 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 110 | 0.030 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2016 | 93 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1553 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1202 | 0.030 |
Why?
|
| Methamphetamine | 1 | 2016 | 198 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 2016 | 156 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 524 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 3720 | 0.020 |
Why?
|
| Adolescent | 1 | 2022 | 6737 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5486 | 0.020 |
Why?
|
| Male | 1 | 2020 | 26863 | 0.010 |
Why?
|